Company / Operating Cash Flow
Phio Pharmaceuticals Corp. Operating Cash Flow History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$8.6M
FY2020
5-year range
-$9.5M / -$7.3M
FY2016-FY2020
Trend
-15.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$10M to -$9M over the past 2 years.
Based on SEC 10-K filings.
-$9M in FY2020.
Improved from -$10M to -$9M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, operating cash flow decreased 15.0% year-over-year.
- Peak operating cash flow was recorded in FY2013.
- Lowest operating cash flow in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$8.6M | -15.0% |
| FY2019 | -$7.5M | +21.0% |
| FY2018 | -$9.5M | -22.6% |
| FY2017 | -$7.8M | -6.1% |
| FY2016 | -$7.3M | -44.5% |
| FY2013 | -$5.1M | +0.0% |
| FY2012 | -$5.1M | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026